Clinical research reported by Schmidt et al. showed that breast globin and HLA-DRB1 ∗04 : 01; HLA-DRB1 ∗07 : 01 as prepared by Tetramer Technology can detect the specific Tregs in breast cancer patients [41]. Here, HLA-DRB1 is linked to breast carcinoma.